Blog
RSS FeedPosted by Michael Wonder on 21 May 2021
Biosimilar bevacizumab on the PBS - information for health professionals and patients
21 May 2021 - A biosimilar brand of bevacizumab (Mvasi) will be listed on the PBS on 1 June 2021. Information ...
Posted by Michael Wonder on 18 May 2021
PBS win to bring relief for people with migraine but concerns over limitations remain
16 May 2021 - For Devonport resident Nette Judson a migraine attack causes her to struggle to walk and talk ...
Posted by Michael Wonder on 14 May 2021
Migraine drug Emgality to be listed on PBS, saving sufferers thousands of dollars
13 May 2021 - People living with migraine will no longer face the financial headache of forking out thousands of ...
Posted by Michael Wonder on 12 May 2021
Agenda items scheduled for review by the PBAC under the process for reviewing recommendations not accepted by applicants
13 May 2021 - The revised agenda for the July 2021 PBAC meeting notes seven medicines/medicinal preparations for review under ...
Posted by Michael Wonder on 11 May 2021
Budget 2021–22: generational change and record investment in the health of Australians
11 May 2021 - A joint media release outlining the Morrison Government's $121.4 billion in 2021–22 and $503 billion investment into ...
Posted by Michael Wonder on 11 May 2021
Expensive migraine drug Emgality added to PBS
11 May 2021 - An expensive migraine drug will be listed on the Pharmaceuticals Benefits Scheme, making it affordable for ...
Posted by Michael Wonder on 11 May 2021
Health front and centre of economic recovery
11 May 2021 - Treasurer Josh Frydenberg places the nation’s health, wellbeing and recovery from COVID-19 front and centre of ...
Posted by Michael Wonder on 10 May 2021
Budget 2021: Alison Day meets with Greg Hunt to help other cancer sufferers
10 May 2021 - Mum of two Alison Day - who has a terminal breast cancer diagnosis - has secured more ...
Posted by Michael Wonder on 09 May 2021
Families plead for PBS listing for ‘life-saving’ cystic fibrosis drug
8 May 2021 - A new drug is being hailed as a “game-changer” for cystic fibrosis sufferers as the government is ...
Posted by Michael Wonder on 07 May 2021
Updated agenda for the July 2021 PBAC meeting
7 May 2021 - The agenda for the July 2021 PBAC meeting has been updated. ...
Posted by Michael Wonder on 01 May 2021
Schedule of Pharmaceutical Benefits - 1 May 2021
1 May 2021 - The May 2021 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 30 Apr 2021
Cancer expert to head review into efficient and equitable access to chemotherapy medicines
1 May 2021 - Renowned cancer expert Professor Sanchia Aranda AM will head an Australian Government review aimed at making ...
Posted by Michael Wonder on 30 Apr 2021
Historic PBS listing for Australians with a rare epilepsy condition
30 April 2021 - In an historic first, Australians living with a rare form of epilepsy will have access to a ...
Posted by Michael Wonder on 25 Apr 2021
Public Summary Documents (rejections/deferrals/other matters) - December 2020 PBAC intracycle meeting
23 April 2021 - The Public Summary Documents (rejections/deferrals/other matters) from the December 2020 PBAC intracycle meeting are now available. ...
Posted by Michael Wonder on 25 Apr 2021
The price of a Vertex cystic fibrosis treatment stirs anger in Australia
23 April 2021 - The latest dustup over the cost of cystic fibrosis medicines sold by Vertex Pharmaceuticals is taking ...